Novartis biggest hope against coronavirus – Malaria drug
Vas Narasimhan, Chief Executive, Novartis said to Swiss newspaper – SonntagsZeitung on March 29 that his Sandoz generics unit’s malaria, lupus and arthritis medication hydroxychloroquine is the company’s greatest ray of hope to fight against the coronavirus.
The company has vowed to donate 130 million dosages of the drug and is supporting clinical trials, which Donald Trump, U.S. President has been promoting and can be authorized for usage against the COVID-19.
Other firms including Bayer BAYGn.DE and TEVA.TA has also consented to contribute hydroxychloroquine or similar drugs, and Gilead Sciences GILD.O is checking its speculative medicine remdesivir for COVID-19.
Narasimhan said, “Pre-clinical studies in animal models, and the first data from clinical research studies, reveal that hydroxychloroquine works against coronavirus,” and “We’re working with Swiss hospitals on possible therapy protocols for the clinical use of the medicine, yet it’s prematurely to say anything at this moment.”
He added, “The firm is presently seeking extra active medicine components to make more hydroxychloroquine drug, and clinical trials should be successful.
3 various other Novartis medications – Jakavi for cancer, Gilenya for multiple sclerosis and Ilaris for fever are being examined for their result on problems associated with coronavirus. This complies with separate initiatives to re-purpose medicines developed by companies like Roche ROG.S and Sanofi SASY.PA to treat difficulties associated with the infection.
The company was established in 1996 through a merger of Ciba-Geigy as well as Sandoz. Novartis and its precursor companies trace roots back to 250 years, with an abundant history of creating ingenious items. From the start in the production of artificial textile dyes, the business that ultimately came to be Novartis branched out into producing chemicals and eventually pharmaceuticals. The history of the company traces the assembling destinies of 3 firms: Geigy, Ciba, and also Sandoz.
Author : Sruthi S